Medications

Triplet therapy slows refractory multiple myeloma

(HealthDay)—A once-weekly regimen of selinexor, bortezomib, and dexamethasone slows the progression of relapsed or refractory multiple myeloma, according to a study published in the Nov. 14 issue of The Lancet.

Oncology & Cancer

Laparoscopic resection may be an option for CRC liver metastases

(HealthDay)—For patients with metastatic colorectal cancer who have resectable liver metastases, survival outcomes at five years do not differ significantly for treatment with laparoscopic versus open liver resection, according ...

Cardiology

Study highlights potential targets for heart failure prevention

The prevalence of heart failure in the United States is a growing concern. A new study led by a Yale physician analyzes the variations in how often heart failure occurs in patients with risk factors such as hypertension, ...

Surgery

Skilled surgeons boost colon cancer survival by 70%

Patients of more technically skilled surgeons, as assessed by review of operative video, have better long-term survival after surgery for the treatment of colon cancer, reports a new Northwestern Medicine study.

Oncology & Cancer

Trial targets deadly lung cancer

With more than 650 Australians diagnosed with malignant mesothelioma last year, Flinders University is leading new research to discover alternatives to chemotherapy and even prevent deaths by early detection in future.

page 1 from 40